After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Agios Pharmaceuticals Inc is $2.03B. A total of 0.99 million shares were traded on the day, compared to an average of 870.60K shares.
In the most recent transaction, Washburn Theodore James Jr. sold 2,272 shares of AGIO for 34.39 per share on Feb 05 ’25. After the transaction, the Principal Accounting Officer now owns 5,437 company shares. In a previous transaction on Jan 06 ’25, Milanova Tsveta sold 2,804 shares at 32.18 per share. AGIO shares that Chief Commercial Officer owns now total 18,906.
Among the insiders who bought shares, Milanova Tsveta acquired of 2,804 shares on Jan 03 ’25 at a per-share price of $31.84. In another insider transaction, Scadden David sold 200 shares at $46.28 per share on Dec 11 ’24. Company shares held by the Director now total 15,483.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $26.66.
As of this writing, AGIO has an earnings estimate of -$1.76 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$1.47 per share and a lower estimate of -$1.93.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $26.96, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.
